Comment on "Will HPV vaccination prevent cervical cancer".
作者信息
Zhang Shaokai, Zhao Fanghui
机构信息
Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, China.
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
出版信息
BMC Med. 2020 Apr 27;18(1):115. doi: 10.1186/s12916-020-01589-8.
Abstract
摘要
相似文献
1
Comment on "Will HPV vaccination prevent cervical cancer".关于《人乳头瘤病毒疫苗能否预防宫颈癌》的评论
BMC Med. 2020 Apr 27;18(1):115. doi: 10.1186/s12916-020-01589-8.
2
3
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.人乳头瘤病毒（HPV）预防性疫苗接种：对公共卫生的挑战及对筛查的影响
Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18.
4
[Cervical cancer prevention: the impact of HPV vaccination].宫颈癌预防：人乳头瘤病毒疫苗的影响
Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. doi: 10.1016/j.gyobfe.2006.01.036. Epub 2006 Mar 10.
5
[Human papillomavirus infection and vaccination].[人乳头瘤病毒感染与疫苗接种]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):106-112. doi: 10.3760/cma.j.issn.0253-9624.2018.01.021.
6
HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.南非的人乳头瘤病毒疫苗接种：抗击宫颈癌的一剂希望之针。
Cancer Cytopathol. 2016 Oct;124(10):695-698. doi: 10.1002/cncy.21738. Epub 2016 May 16.
7
HPV genotypes: implications for worldwide cervical cancer screening and vaccination.人乳头瘤病毒基因型：对全球宫颈癌筛查和疫苗接种的影响
Lancet Oncol. 2010 Nov;11(11):1013-4. doi: 10.1016/S1470-2045(10)70249-7. Epub 2010 Oct 15.
8
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.人乳头瘤病毒16/18疫苗的预期临床益处和成本效益
J Natl Cancer Inst. 2004 Apr 21;96(8):604-15. doi: 10.1093/jnci/djh104.
9
[Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].人乳头瘤病毒相关疾病免疫预防专家共识（节略版）
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1218-1235. doi: 10.3760/cma.j.issn.0253-9624.2019.12.006.
10
[Vaccination against human papillomavirus for the prevention of cervical cancer].[接种人乳头瘤病毒疫苗预防宫颈癌]
Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4.
引用本文的文献
1
circRNA_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microRNA-654-3p.circRNA_0000285 通过海绵吸附 microRNA-654-3p 抑制宫颈癌细胞的活力并促进其凋亡。
Bioengineered. 2022 Mar;13(3):5251-5261. doi: 10.1080/21655979.2022.2037870.
2
A review of vaccine effects on women in light of the COVID-19 pandemic.鉴于新冠疫情对疫苗在女性群体中的作用的综述。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):812-820. doi: 10.1016/j.tjog.2020.09.006. Epub 2020 Sep 11.
本文引用的文献
1
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.HPV 疫苗接种和宫颈筛查对宫颈癌消除的影响：78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):575-590. doi: 10.1016/S0140-6736(20)30068-4. Epub 2020 Jan 30.
2
Will HPV vaccination prevent cervical cancer?HPV 疫苗能否预防宫颈癌？
J R Soc Med. 2020 Feb;113(2):64-78. doi: 10.1177/0141076819899308. Epub 2020 Jan 21.
3
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.人群水平影响和 herd 效应：人乳头瘤病毒疫苗接种计划引入后的更新系统评价和荟萃分析。
Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26.
4
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.大肠杆菌生产的双价人乳头瘤病毒疫苗的疗效、安全性和免疫原性：一项随机临床试验的中期分析。
J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074.
5
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.12-13 岁接种二价 HPV 疫苗后 20 岁时的宫颈癌患病率：苏格兰的回顾性人群研究。
BMJ. 2019 Apr 3;365:l1161. doi: 10.1136/bmj.l1161.
6
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.四价人乳头瘤病毒疫苗的影响与效果：对十年真实世界经验的系统评价
Clin Infect Dis. 2016 Aug 15;63(4):519-27. doi: 10.1093/cid/ciw354. Epub 2016 May 26.
7
Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.未来预防性人乳头瘤病毒疫苗试验的主要终点：针对感染和免疫桥接。
Lancet Oncol. 2015 May;16(5):e226-33. doi: 10.1016/S1470-2045(15)70075-6.
8
Present status of human papillomavirus vaccine development and implementation.人乳头瘤病毒疫苗的研发与实施现状。
Lancet Oncol. 2015 May;16(5):e206-16. doi: 10.1016/S1470-2045(14)70481-4.
9
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.基于人群的 HPV 疫苗接种计划对宫颈异常的影响：一项数据关联研究。
BMC Med. 2013 Oct 22;11:227. doi: 10.1186/1741-7015-11-227.
Zotero 插件